Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lexeo Therapeutics, Inc. | 10%+ Owner | Common Stock | 2.57M | $33.9M | $13.22 | Nov 7, 2023 | By Longitude Venture Partners IV, L.P. |
Vera Therapeutics, Inc. | 10%+ Owner | Class A Common Stock | 1.71M | $30.9M | $18.00 | Feb 6, 2023 | Indirect |
Lexeo Therapeutics, Inc. | 10%+ Owner | Series A convertible preferred stock | 0 | Nov 7, 2023 | By Longitude Venture Partners IV, L.P. | ||
Lexeo Therapeutics, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | Nov 7, 2023 | By Longitude Venture Partners IV, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXEO | Lexeo Therapeutics, Inc. | Nov 7, 2023 | 5 | $5M | 4 | Nov 9, 2023 | 10%+ Owner |
LXEO | Lexeo Therapeutics, Inc. | Nov 2, 2023 | 0 | $0 | 3 | Nov 2, 2023 | 10%+ Owner |
VERA | Vera Therapeutics, Inc. | Feb 6, 2023 | 1 | $12M | 4 | Feb 8, 2023 | 10%+ Owner |
VERA | Vera Therapeutics, Inc. | Feb 10, 2022 | 1 | $5M | 4 | Apr 5, 2022 | 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 18, 2021 | 3 | $10M | 4 | May 18, 2021 | 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 0 | $0 | 3 | May 13, 2021 | 10%+ Owner |